PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 201 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2015. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $11,188,000 | -48.3% | 244,008 | -33.3% | 0.41% | -49.6% |
| Q2 2018 | $21,636,000 | -14.5% | 365,787 | -1.6% | 0.82% | -19.5% |
| Q1 2018 | $25,304,000 | -36.4% | 371,840 | -7.7% | 1.01% | -33.9% |
| Q4 2017 | $39,804,000 | -10.2% | 402,668 | +8.8% | 1.53% | -15.0% |
| Q3 2017 | $44,312,000 | +59.6% | 370,035 | +16.5% | 1.80% | +55.4% |
| Q2 2017 | $27,765,000 | +96.8% | 317,680 | -16.2% | 1.16% | +100.3% |
| Q1 2017 | $14,110,000 | +124.1% | 379,289 | +1102.0% | 0.58% | +83.2% |
| Q1 2015 | $6,297,000 | -34.4% | 31,556 | -37.8% | 0.32% | -37.9% |
| Q4 2014 | $9,600,000 | +36.0% | 50,721 | +71.5% | 0.51% | +21.5% |
| Q3 2014 | $7,057,000 | – | 29,580 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |